These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32850288)

  • 1. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Am J Med Sci; 2022 Aug; 364(2):181-191. PubMed ID: 34800429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis.
    He J; Yang Z; Wu Z; Wang L; Xu S; Zou Q; Yuan Y; Li D
    Onco Targets Ther; 2019; 12():2955-2965. PubMed ID: 31114239
    [No Abstract]   [Full Text] [Related]  

  • 5. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
    Li J; Yang Z; Huang S; Li D
    Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Biomark Med; 2020 Nov; 14(16):1573-1584. PubMed ID: 32960074
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
    Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
    Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
    Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
    Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
    Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
    Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
    Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
    Han Y; Zhang W; Liu Y
    World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
    Wang M; Gong B; Li Y; Wang Y
    Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.
    Tian X; Wang Q; Li Y; Hu J; Wu L; Ding Q; Zhang C
    Pathol Oncol Res; 2015 Jan; 21(1):195-201. PubMed ID: 24985031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
    Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
    Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.
    Tsukagoshi M; Wada S; Yokobori T; Altan B; Ishii N; Watanabe A; Kubo N; Saito F; Araki K; Suzuki H; Hosouchi Y; Kuwano H
    Cancer Sci; 2016 Feb; 107(2):116-22. PubMed ID: 26608587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.
    Ormanns S; Altendorf-Hofmann A; Jackstadt R; Horst D; Assmann G; Zhao Y; Bruns C; Kirchner T; Knösel T
    Br J Cancer; 2015 Nov; 113(10):1460-6. PubMed ID: 26469831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.